Literature DB >> 26049631

You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.

Stéphanie Olivier-Van Stichelen1, John A Hanover.   

Abstract

PURPOSE OF REVIEW: The O-linked N-acetylglucosamine (O-GlcNAc) modification is both responsive to nutrient availability and capable of altering intracellular cellular signalling. We summarize data defining a role for O-GlcNAcylation in metabolic homeostasis and epigenetic regulation of development in the intrauterine environment. RECENT
FINDINGS: O-GlcNAc transferase (OGT) catalyzes nutrient-driven O-GlcNAc addition and is subject to random X-inactivation. OGT plays key roles in growth factor signalling, stem cell biology, epigenetics and possibly imprinting. The O-GlcNAcase, which removes O-GlcNAc, is subject to tight regulation by higher order chromatin structure. O-GlcNAc cycling plays an important role in the intrauterine environment wherein OGT expression is an important biomarker of placental stress.
SUMMARY: Regulation of O-GlcNAc cycling by X-inactivation, epigenetic regulation and nutrient-driven processes makes it an ideal candidate for a nutrient-dependent epigenetic regulator of human disease. In addition, O-GlcNAc cycling influences chromatin modifiers critical to the regulation and timing of normal development including the polycomb repression complex and the ten-eleven translocation proteins mediating DNA methyl cytosine demethylation. The pathway also impacts the hypothalamic-pituitary-adrenal axis critical to intrauterine programming influencing disease susceptibility in later life.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26049631      PMCID: PMC4479189          DOI: 10.1097/MCO.0000000000000188

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  53 in total

1.  O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.

Authors:  Hyonchol Jang; Tae Wan Kim; Sungho Yoon; Soo-Youn Choi; Tae-Wook Kang; Seon-Young Kim; Yoo-Wook Kwon; Eun-Jung Cho; Hong-Duk Youn
Journal:  Cell Stem Cell       Date:  2012-05-17       Impact factor: 24.633

2.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

3.  Paternal diet defines offspring chromatin state and intergenerational obesity.

Authors:  Anita Öst; Adelheid Lempradl; Eduard Casas; Melanie Weigert; Theodor Tiko; Merdin Deniz; Lorena Pantano; Ulrike Boenisch; Pavel M Itskov; Marlon Stoeckius; Marius Ruf; Nikolaus Rajewsky; Gunter Reuter; Nicola Iovino; Carlos Ribeiro; Mattias Alenius; Steffen Heyne; Tanya Vavouri; J Andrew Pospisilik
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

4.  Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT).

Authors:  Qiao Zhang; Xiaoguang Liu; Wenqi Gao; Pishun Li; Jingli Hou; Jiwen Li; Jiemin Wong
Journal:  J Biol Chem       Date:  2014-01-06       Impact factor: 5.157

Review 5.  The role of epigenetics in the pathology of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

6.  O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat.

Authors:  Hai-Bin Ruan; Marcelo O Dietrich; Zhong-Wu Liu; Marcelo R Zimmer; Min-Dian Li; Jay Prakash Singh; Kaisi Zhang; Ruonan Yin; Jing Wu; Tamas L Horvath; Xiaoyong Yang
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

7.  X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body.

Authors:  Stéphanie Olivier-Van Stichelen; John A Hanover
Journal:  Front Genet       Date:  2014-08-04       Impact factor: 4.599

8.  Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia.

Authors:  Nelly Mauras; Paul Mazaika; Bruce Buckingham; Stuart Weinzimer; Neil H White; Eva Tsalikian; Tamara Hershey; Allison Cato; Peiyao Cheng; Craig Kollman; Roy W Beck; Katrina Ruedy; Tandy Aye; Larry Fox; Ana Maria Arbelaez; Darrell Wilson; Michael Tansey; William Tamborlane; Daniel Peng; Matthew Marzelli; Karen K Winer; Allan L Reiss
Journal:  Diabetes       Date:  2014-12-08       Impact factor: 9.461

Review 9.  Chromosome imbalance as a driver of sex disparity in disease.

Authors:  Lara K Abramowitz; Stéphanie Olivier-Van Stichelen; John A Hanover
Journal:  J Genomics       Date:  2014-04-01

10.  Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting naïve to primed cell transition.

Authors:  Christopher M Speakman; Tanja C E Domke; Wikrom Wongpaiboonwattana; Kelly Sanders; Manikhandan Mudaliar; Daan M F van Aalten; Geoffrey J Barton; Marios P Stavridis
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

View more
  24 in total

Review 1.  Nutrient sensor signaling pathways and cellular stress in fetal growth restriction.

Authors:  Bethany Hart; Elizabeth Morgan; Emilyn U Alejandro
Journal:  J Mol Endocrinol       Date:  2019-02-01       Impact factor: 5.098

Review 2.  Redox biology and the interface between bioenergetics, autophagy and circadian control of metabolism.

Authors:  Adam R Wende; Martin E Young; John Chatham; Jianhua Zhang; Namakkal S Rajasekaran; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2016-05-27       Impact factor: 7.376

Review 3.  O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.

Authors:  John A Hanover; Weiping Chen; Michelle R Bond
Journal:  J Bioenerg Biomembr       Date:  2018-03-29       Impact factor: 2.945

4.  OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance.

Authors:  Yunfan Yang; Xiruo Li; Harding H Luan; Bichen Zhang; Kaisi Zhang; Jin Hyun Nam; Zongyu Li; Minnie Fu; Alexander Munk; Dongyan Zhang; Simeng Wang; Yuyang Liu; João Paulo Albuquerque; Qunxiang Ong; Rui Li; Qi Wang; Marie E Robert; Rachel J Perry; Dongjun Chung; Gerald I Shulman; Xiaoyong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

5.  O-GlcNAc homeostasis contributes to cell fate decisions during hematopoiesis.

Authors:  Zhen Zhang; Matthew P Parker; Stefan Graw; Lesya V Novikova; Halyna Fedosyuk; Joseph D Fontes; Devin C Koestler; Kenneth R Peterson; Chad Slawson
Journal:  J Biol Chem       Date:  2018-12-06       Impact factor: 5.157

6.  Disruption of O-GlcNAc homeostasis during mammalian oocyte meiotic maturation impacts fertilization.

Authors:  Luhan T Zhou; Raquel Romar; Mary Ellen Pavone; Cristina Soriano-Úbeda; John Zhang; Chad Slawson; Francesca E Duncan
Journal:  Mol Reprod Dev       Date:  2019-02-21       Impact factor: 2.609

Review 7.  GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.

Authors:  Roberto De Masi; Stefania Orlando
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

8.  Dietary glycemic index, glycemic load, and lung cancer risk: A case-control study in Los Angeles County.

Authors:  Chun-Pin Chang; Travis J Meyers; Alan Fu; Ming-Yan Zhang; Donald P Tashkin; Jian-Yu Rao; Wendy Cozen; Thomas M Mack; Mia Hashibe; Hal Morgenstern; Zuo-Feng Zhang
Journal:  Cancer Epidemiol       Date:  2020-10-08       Impact factor: 2.984

Review 9.  Brain on food: The neuroepigenetics of nutrition.

Authors:  Anoumid Vaziri; Monica Dus
Journal:  Neurochem Int       Date:  2021-06-13       Impact factor: 4.297

10.  Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.

Authors:  Agata Steenackers; Stéphanie Olivier-Van Stichelen; Steffi F Baldini; Vanessa Dehennaut; Robert-Alain Toillon; Xuefen Le Bourhis; Ikram El Yazidi-Belkoura; Tony Lefebvre
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.